Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Researchers raise TPP legislation concerns

January 25, 2016 Manufacturing and Production, Sales and Marketing Legislation, Trans-Pacific Partnership, tpp, trade agreement

Academics have warned that global trade regulations under consideration by the US and other countries could prevent access to medicines …
News

FDA approves new uses for BMS’ Opdivo/Yervoy cancer combo

January 25, 2016 Sales and Marketing BMS, Bristol-Myers Squibb, Yervoy, ipilimumabm melanoma, nivolumab, opdivo, skin cancer

The FDA has granted Bristol Myers Squibb an expanded indication for its two-cancer drug regimen Opdivo and Yervoy, to treat …
News

AbbVie and MD Anderson in cancer research partnership

January 25, 2016 Research and Development, Sales and Marketing AbbVie, MD Anderson Cancer Centre, immuno-oncology

AbbVie has announced a new partnership with The University of Texas MD Anderson Cancer Centre, using its immunotherapy platform to …
News

Patients sue J&J for $800m for ‘hiding antibiotic side effects’

January 22, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Janssen, Johnson and Johnson, Levaquin, Margaret Hamburg, lawsuit, levofloxacin

Six users of Johnson & Johnson’s antibiotic Levaquin are to sue the company for up to $870 million, claiming the …
News

FDA approves new Kyprolis combo for multiple myeloma

January 22, 2016 Medical Communications, Sales and Marketing Amgen, FDA, Kyprolis, carfilzomib, multiple myeloma, myeloma

Amgen’s Kyprolis has been given another endorsement by the FDA as a multiple myeloma treatment – its second in six …
News

NICE ‘yes’ for BMS skin cancer drug Opdivo

January 22, 2016 Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, NICE, melanoma, nivolumab, opdivo, skin cancer

NICE has approved Bristol-Myers Squibb’s skin cancer immunotherapy Opdivo (nivolumab) in final draft guidance as monotherapy for NHS patients in England …
News

Martin Shkreli subpoenaed in US to testify over drug pricing

January 21, 2016 Medical Communications, Sales and Marketing Daraprim, Howard Schiller, Martin Shkreli, Valeant, turing

Former pharma chief exec Martin Shkreli has been issued with a subpoena by the US House of representatives, compelling him …
News

AbbVie/Roche’s venetoclax bags FDA Breakthrough Therapy Designation

January 21, 2016 Sales and Marketing AbbVie, Breakthrough Therapy Designation, FDA, Roche, venetoclax

AbbVie and Roche’s cancer drug venetoclax has been granted Breakthrough Therapy Designation by the FDA in combination with rituximab for …
News

Lilly awaits FDA review of new arthritis treatment

January 20, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Eli Lilly, FDA, Incyte, NDA, baricitinib, lilly, new drug application, rheumatoid arthritis

Eli Lilly has submitted a new drug application (NDA) to the FDA for baricitinib as a treatment for moderate-to-severe rheumatoid …
News

Arzerra approved by US FDA for leukaemia

January 20, 2016 Research and Development, Sales and Marketing Afrezza, CLL, FDA, Genmab, Novartis, chronic lymphocytic leukaemia, ofatumumab, sBLA, supplementary biologics license application

The FDA has signed-off a supplemental Biologics License Application (sBLA), meaning Arzerra is approved for extended treatment of patients who …
News

Sobi launches new haemophilia treatment in UK

January 19, 2016 Manufacturing and Production, Sales and Marketing elocta, haemophilia a, sobi

Swedish Orphan Biovitrum Ltd (Sobi) has launched its haemophilia A treatment Elocta (efmoroctocog alfa) in the UK, following its EU …
News

Merck appoints new executive board members

January 19, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck

Merck has appointed two new members to its executive board: Udit Batra (45), head of the Life Science business sector, …
Appointment

Ergomed announces board changes

January 19, 2016 Manufacturing and Production, Research and Development, Sales and Marketing ergomed, primevigilance

Ergomed, a specialist provider of drug development services to the pharmaceutical industry, has announced that Neil Clark, current chief financial …
Appointment

FDA criticised for safety data flaws

January 18, 2016 Sales and Marketing FDA, US Government Accountability Office, pharmacovigilance, post-marketing data, safety

The US FDA is failing to meet its ‘statutorily required’ obligations to track safety data for drugs post-marketing and publish …
News

Two new US approvals for Novartis’ Cosentyx

January 18, 2016 Research and Development, Sales and Marketing Cosentyx, Novartis

Novartis has won FDA approval for Cosentyx (secukinumab) for the treatment of two new indications – adults with active ankylosing …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026